Please login to the form below

Not currently logged in
Email:
Password:

NIHR appoints Simon Denegri to lead public engagement in research

Former AMRC CEO joins as national director for public participation and engagement in research

The UK's National Institute for Health Research (NIHR) has appointed Simon Denegri as the Institute's national director for public participation and engagement in research.

In his new position Denegri will be tasked with encouraging more people to take part in health and social care research in the UK.

This will include giving patients the right information and support to be able to talk to NHS staff about ongoing research into their condition.

Denegri, who is also currently chair of the NIHR's Involve programme, will work closely with NHS organisations, Public Health England, Healthwatch, patient groups and other stakeholders in this new role.

His previous roles include serving as CEO of Ovarian Cancer Action for six months during 2011 and CEO of the Association of Medical Research Charities (AMRC) from 2006 until 2011.

Prior to his role at the AMRC, Denegri was director of corporate communications at the Royal College of Physicians of London from 2003.

23rd March 2012

Share

Related Hub content

    Your search did not contain any words. Please try again.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN LEC

Welcome to our world. We specialise in creating, launching and revitalising brands all over the world. We blend science, creative,...

Latest intelligence

More of the same: The importance of strategic communications planning for biosimilar entry
GCI Health's Hannah Morris considers the importance of strategic communications planning for biosimilar entry, a market anticipated to deliver between €8-26bn in savings across the European Union by 2020....
Online Physician Communities
How can pharma realise the power of digital?
Firstly, by making it owned and driven by the most senior leadership team in the business...
Remapping the market: Does Pharma's global model need a shake up?
For patients, carers and professionals, wherever they are in the world, digital technology is inherent in their everyday lives. Digital is, so to speak, a global language. The success of...